CN112274600A - Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation - Google Patents

Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation Download PDF

Info

Publication number
CN112274600A
CN112274600A CN202011271861.5A CN202011271861A CN112274600A CN 112274600 A CN112274600 A CN 112274600A CN 202011271861 A CN202011271861 A CN 202011271861A CN 112274600 A CN112274600 A CN 112274600A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine composition
high blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011271861.5A
Other languages
Chinese (zh)
Inventor
成名
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011271861.5A priority Critical patent/CN112274600A/en
Publication of CN112274600A publication Critical patent/CN112274600A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood fat and a traditional Chinese medicine preparation, and relates to the technical field of health preservation and health care, wherein the traditional Chinese medicine composition comprises the following components in parts by weight: 0.5-1.5 parts of gastrodia elata, 0.3-0.6 part of ligusticum wallichii, 1-3 parts of salvia miltiorrhiza, 1-3 parts of eucommia ulmoides, 1-3 parts of poria cocos, 1-2 parts of hawthorn, 2-4 parts of motherwort, 1-3 parts of uncaria, 0.5-1.5 parts of chrysanthemum and 0.5-1.5 parts of folium mori. The traditional Chinese medicine composition disclosed by the invention is prepared from raw materials which are homologous in medicine and food, has the effects of reducing blood fat, reducing blood pressure and dredging blood through mutual matching and synergistic action of the components, and can be used for treating and preventing hypertension and vascular blockage; meanwhile, the traditional Chinese medicine composition has a good adjusting effect on symptoms such as headache, dizziness, cerebral infarction, arteriosclerosis and the like, and the raw materials of the traditional Chinese medicine composition are simple to obtain, low in price, excellent in effect, free of toxicity and side effects, and suitable for long-term use; the traditional Chinese medicine preparation can be prepared into any preparation form, has strong adaptability and remarkable effect of reducing hypertension, hyperglycemia and hyperlipidemia, and has the effective rate of more than 90 percent.

Description

Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation
Technical Field
The invention relates to the technical field of health preservation and health care, in particular to a traditional Chinese medicine composition and a traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood fat.
Background
Three highs are the general term for hyperlipidemia, hypertension and hyperglycemia. They are "rich diseases" derived from modern society, and may exist alone or be related to each other. Such as: diabetes patients are easy to suffer from hypertension or hyperlipidemia at the same time, the hyperlipidemia is also a main factor for the formation and development of arteriosclerosis, and the blood vessel elasticity of the arteriosclerosis patients is poor to aggravate the increase of blood pressure. Therefore, when any one of the three diseases appears, the "three-high disease" is easily formed in the later period.
Among the ten causes of death in Chinese, the mortality associated with metabolic disease is as high as 35.7%, the mortality associated with the third highest accounts for 27% of the total deaths, and the third highest has become the fatal "first killer" for humans.
However, in the three-high population in the market at present, the three-high is mainly regulated and controlled by medicines, and certain side effects are easily generated after long-term taking of the medicines, so how to develop a traditional Chinese medicine composition which has no toxicity or side effects and obvious effect while reducing the three-high is a problem to be solved urgently in the prior art. Therefore, the technical personnel in the field provide a traditional Chinese medicine composition and a traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid so as to solve the problems in the background technology.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition and a traditional Chinese medicine preparation for reducing hypertension, hyperlipidemia and hyperglycemia, wherein the traditional Chinese medicine composition is prepared from raw materials which are homologous in medicine and food, has the effects of reducing blood fat, reducing blood pressure and dredging blood through mutual matching and synergistic action of the components, and can treat and prevent hypertension and vascular blockage; meanwhile, the traditional Chinese medicine composition has a good adjusting effect on symptoms such as headache, dizziness, cerebral infarction, arteriosclerosis and the like, is simple in raw material acquisition, low in price, excellent in effect, free of toxicity and side effects, is suitable for long-term use, and solves the problems in the background art.
In order to achieve the purpose, the invention provides the following technical scheme: a traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia comprises the following components in parts by weight: 0.5-1.5 parts of gastrodia elata, 0.3-0.6 part of ligusticum wallichii, 1-3 parts of salvia miltiorrhiza, 1-3 parts of eucommia ulmoides, 1-3 parts of poria cocos, 1-2 parts of hawthorn, 2-4 parts of motherwort, 1-3 parts of uncaria, 0.5-1.5 parts of chrysanthemum and 0.5-1.5 parts of folium mori.
As a further scheme of the invention: the traditional Chinese medicine composition comprises the following components in parts by weight: 0.5 part of gastrodia elata, 0.3 part of ligusticum wallichii, 1 part of salvia miltiorrhiza, 1 part of eucommia ulmoides, 1 part of poria cocos, 1 part of hawthorn, 2 parts of motherwort, 1 part of uncaria, 0.5 part of chrysanthemum and 0.5 part of mulberry leaves.
As a still further scheme of the invention: the traditional Chinese medicine composition comprises the following components in parts by weight: 1.5 parts of gastrodia elata, 0.6 part of ligusticum wallichii, 3 parts of salvia miltiorrhiza, 3 parts of eucommia ulmoides, 3 parts of poria cocos, 2 parts of hawthorn, 4 parts of motherwort, 3 parts of uncaria, 1.5 parts of chrysanthemum and 1.5 parts of mulberry leaves.
As a still further scheme of the invention: the traditional Chinese medicine composition comprises the following components in parts by weight: 1 part of gastrodia elata, 0.5 part of ligusticum wallichii, 2 parts of salvia miltiorrhiza, 2 parts of eucommia ulmoides, 2 parts of poria cocos, 1.5 parts of hawthorn, 3 parts of motherwort, 2 parts of uncaria, 1 part of chrysanthemum and 1 part of mulberry leaves.
As a still further scheme of the invention: the traditional Chinese medicine composition is an aqueous extract of raw material components.
As a still further scheme of the invention: the extraction frequency of the water extract is not less than 3 times, the water extraction time is 1-3 h each time, and the water adding amount of the water extraction is 5-10 times of the total mass of the raw materials each time.
A traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid comprises the traditional Chinese medicine composition for reducing high blood pressure, high blood lipid and high blood lipid.
As a still further scheme of the invention: the dosage form of the traditional Chinese medicine preparation is any one dosage form in the prescription science.
As a still further scheme of the invention: the Chinese medicinal preparation is granule, tablet, pill, paste, capsule, powder, decoction, oral liquid or teabag.
As a still further scheme of the invention: the components of the traditional Chinese medicine preparation also comprise pharmaceutically acceptable auxiliary materials.
The medicine mechanism of each component of the invention is as follows:
gastrodia elata: has effects in calming endogenous wind, relieving spasm, suppressing liver yang, dispelling pathogenic wind, and dredging collaterals; it can be used for treating stirring of liver-wind, convulsive epilepsy, convulsion, vertigo, headache, numbness of limbs, hemiplegia, and rheumatalgia.
Ligusticum wallichii: it is commonly used for promoting blood circulation and activating qi-flowing, dispelling pathogenic wind and relieving pain, rhizoma Ligustici Chuanxiong is pungent, warm, fragrant and dry, and can disperse and ascend to the vertex; enter the blood system and descend to reach the blood sea; promoting blood circulation and removing blood stasis, and is suitable for various diseases caused by blood stasis; it has good effect in dispelling pathogenic wind and relieving pain, and can be used for treating headache, rheumatalgia, etc.
Red sage root: has the effects of promoting blood circulation, removing blood stasis, dredging channels, relieving pain, clearing away heart-fire, relieving restlessness, cooling blood and eliminating carbuncle; can be used for treating thoracic obstruction, heart pain, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain.
Eucommia ulmoides: eucommia bark contains various effective components, wherein more than 40 compounds such as iridoid, lignanoid, phenylpropanoid and the like are included, and the pharmacological action is wide; has effects of lowering blood pressure, resisting aging, resisting tumor, resisting bacteria and virus, and enhancing immunity.
Tuckahoe, poria cocos: has effects in promoting diuresis, eliminating dampness, invigorating spleen, and calming heart; can be used for treating edema, oliguria, phlegm and fluid retention, dizziness, palpitation, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia.
Hawthorn fruit: has the functions of reducing blood fat and blood pressure, strengthening heart, resisting arrhythmia, strengthening spleen, stimulating appetite, promoting digestion, removing food stagnation, promoting blood circulation, eliminating phlegm, etc. and has excellent curative effect on chest, diaphragm, spleen fullness, hernia, blood stasis, amenorrhea, etc.
Motherwort: has the effects of promoting blood circulation, regulating menstruation, inducing diuresis, relieving swelling, and clearing away heat and toxic materials; can be used for treating menoxenia, dysmenorrhea, amenorrhea, lochiorrhea, edema, oliguria, pyocutaneous disease, and toxic swelling.
Uncaria: has the efficacies of clearing heat and calming liver, calming wind and arresting convulsion, and the modern pharmacological experiment also proves that the uncaria has the function of reducing blood pressure.
Chrysanthemum: has effects in dispelling pathogenic wind, clearing away heat, suppressing hyperactive liver, and improving eyesight, and contains essential oil, flavonoids, amino acids, and trace elements as main ingredients; can regulate coronary atherosclerosis, accelerate cholesterol metabolism, and has antibacterial, antiviral, antiinflammatory, and antipyretic effects.
Mulberry leaf: has effects in clearing away lung heat, moistening dryness, relieving cough, removing heat, eliminating phlegm, and treating night sweat; nourishing liver, removing liver fire, improving eyesight, treating dizziness and insomnia, and relieving eye fatigue; detumescence, blood heat clearing, dysentery and abdominal pain treating, weight reducing, loempe removing, big and small intestine benefiting; anti-stress, cooling blood, lowering blood pressure, reducing blood lipid, preventing myocardial infarction and cerebral hemorrhage, relieving headache, and promoting hair growth; reducing blood sugar and resisting diabetes.
Compared with the prior art, the invention has the beneficial effects that: the invention discloses a traditional Chinese medicine composition and a traditional Chinese medicine preparation for reducing hypertension, hyperlipidemia and hyperglycemia, wherein the traditional Chinese medicine composition is prepared from raw materials which are homologous in medicine and food, has the effects of reducing blood fat, reducing blood pressure and dredging blood through the mutual matching and synergistic effect of the components, and can treat and prevent hypertension and vascular blockage; meanwhile, the traditional Chinese medicine composition has a good adjusting effect on symptoms such as headache, dizziness, cerebral infarction, arteriosclerosis and the like, and the raw materials of the traditional Chinese medicine composition are simple to obtain, low in price, excellent in effect, free of toxicity and side effects, and suitable for long-term use;
the traditional Chinese medicine preparation disclosed by the invention has all effects of the traditional Chinese medicine composition, can be prepared into any preparation form, is strong in adaptability, has an obvious effect of reducing hypertension, hyperglycemia and hyperlipidemia, and has an effective rate of more than 90%.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the embodiment of the present invention, the first and second substrates,
example 1
A traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia comprises the following components in parts by weight: 0.5 part of gastrodia elata, 0.3 part of ligusticum wallichii, 1 part of salvia miltiorrhiza, 1 part of eucommia ulmoides, 1 part of poria cocos, 1 part of hawthorn, 2 parts of motherwort, 1 part of uncaria, 0.5 part of chrysanthemum and 0.5 part of mulberry leaves.
Further, the traditional Chinese medicine composition is an aqueous extract of the raw material components.
Furthermore, the extraction times of the water extract are 3 times, the water extraction time is 1h each time, and the water addition amount of each time of water extraction is 5 times of the total mass of the raw materials.
A traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid, wherein the active ingredients of the traditional Chinese medicine preparation comprise a traditional Chinese medicine composition for reducing high blood pressure, high blood lipid and high blood lipid.
Furthermore, the dosage form of the traditional Chinese medicine preparation is any one of the dosage forms in the prescription science.
Furthermore, the traditional Chinese medicine preparation is granule.
Still further, the components of the Chinese medicinal preparation also comprise pharmaceutically acceptable auxiliary materials.
Example 2
A traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia comprises the following components in parts by weight: 1.5 parts of gastrodia elata, 0.6 part of ligusticum wallichii, 3 parts of salvia miltiorrhiza, 3 parts of eucommia ulmoides, 3 parts of poria cocos, 2 parts of hawthorn, 4 parts of motherwort, 3 parts of uncaria, 1.5 parts of chrysanthemum and 1.5 parts of mulberry leaves.
Further, the traditional Chinese medicine composition is an aqueous extract of the raw material components.
Furthermore, the extraction times of the water extract are 4 times, the water extraction time is 3 hours each time, and the water adding amount of each time of water extraction is 10 times of the total mass of the raw materials.
A traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid, wherein the active ingredients of the traditional Chinese medicine preparation comprise a traditional Chinese medicine composition for reducing high blood pressure, high blood lipid and high blood lipid.
Furthermore, the dosage form of the traditional Chinese medicine preparation is any one of the dosage forms in the prescription science.
Further, the Chinese medicinal preparation is an ointment.
Still further, the components of the Chinese medicinal preparation also comprise pharmaceutically acceptable auxiliary materials.
Example 3
A traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia comprises the following components in parts by weight: 1 part of gastrodia elata, 0.5 part of ligusticum wallichii, 2 parts of salvia miltiorrhiza, 2 parts of eucommia ulmoides, 2 parts of poria cocos, 1.5 parts of hawthorn, 3 parts of motherwort, 2 parts of uncaria, 1 part of chrysanthemum and 1 part of mulberry leaves.
Further, the traditional Chinese medicine composition is an aqueous extract of the raw material components.
Furthermore, the extraction times of the water extract are 3 times, the water extraction time is 2 hours each time, and the water adding amount of each time of water extraction is 8 times of the total mass of the raw materials.
A traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid, wherein the active ingredients of the traditional Chinese medicine preparation comprise a traditional Chinese medicine composition for reducing high blood pressure, high blood lipid and high blood lipid.
Furthermore, the dosage form of the traditional Chinese medicine preparation is any one of the dosage forms in the prescription science.
Still further, the Chinese medicinal preparation is a tea bag.
Still further, the components of the Chinese medicinal preparation also comprise pharmaceutically acceptable auxiliary materials.
Examples of the experiments
The experimental method comprises the following steps: 90 patients suffering from hypertension, hyperlipidemia and hyperglycemia are randomly divided into three groups, the traditional Chinese medicine preparations prepared in the embodiment 1, the embodiment 2 and the embodiment 3 are respectively taken 1 time in the morning and at night every day, and are continuously taken for 30 days, and the effect statistics is carried out by observing the blood fat, blood pressure and blood sugar conditions of the bodies before and after the administration of related people.
The experimental results are as follows: after 30 days of administration, the blood fat, blood pressure and blood sugar index of 83 people are obviously reduced, the blood fat, blood pressure and blood sugar index of 7 people are not obviously reduced, and the effective rate of reducing the three highs is about 92 percent, so that the traditional Chinese medicine preparation has the effective rate of reducing the three highs of more than 90 percent and has obvious effect of reducing the three highs.
In conclusion, the traditional Chinese medicine composition disclosed by the invention is prepared from raw materials which are homologous in medicine and food, has the effects of reducing blood fat, reducing blood pressure and dredging blood through the mutual matching and synergistic effect of the components, and can be used for treating and preventing hypertension and vascular blockage; meanwhile, the traditional Chinese medicine composition has a good adjusting effect on symptoms such as headache, dizziness, cerebral infarction, arteriosclerosis and the like, and the raw materials of the traditional Chinese medicine composition are simple to obtain, low in price, excellent in effect, free of toxicity and side effects, and suitable for long-term use; the traditional Chinese medicine preparation disclosed by the invention has all effects of the traditional Chinese medicine composition, can be prepared into any preparation form, is strong in adaptability, has an obvious effect of reducing hypertension, hyperglycemia and hyperlipidemia, and has an effective rate of more than 90%.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (10)

1. A traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid is characterized in that: the traditional Chinese medicine composition comprises the following components in parts by weight: 0.5-1.5 parts of gastrodia elata, 0.3-0.6 part of ligusticum wallichii, 1-3 parts of salvia miltiorrhiza, 1-3 parts of eucommia ulmoides, 1-3 parts of poria cocos, 1-2 parts of hawthorn, 2-4 parts of motherwort, 1-3 parts of uncaria, 0.5-1.5 parts of chrysanthemum and 0.5-1.5 parts of folium mori.
2. The traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 1, is characterized in that: the traditional Chinese medicine composition comprises the following components in parts by weight: 0.5 part of gastrodia elata, 0.3 part of ligusticum wallichii, 1 part of salvia miltiorrhiza, 1 part of eucommia ulmoides, 1 part of poria cocos, 1 part of hawthorn, 2 parts of motherwort, 1 part of uncaria, 0.5 part of chrysanthemum and 0.5 part of mulberry leaves.
3. The traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 1, is characterized in that: the traditional Chinese medicine composition comprises the following components in parts by weight: 1.5 parts of gastrodia elata, 0.6 part of ligusticum wallichii, 3 parts of salvia miltiorrhiza, 3 parts of eucommia ulmoides, 3 parts of poria cocos, 2 parts of hawthorn, 4 parts of motherwort, 3 parts of uncaria, 1.5 parts of chrysanthemum and 1.5 parts of mulberry leaves.
4. The traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 1, is characterized in that: the traditional Chinese medicine composition comprises the following components in parts by weight: 1 part of gastrodia elata, 0.5 part of ligusticum wallichii, 2 parts of salvia miltiorrhiza, 2 parts of eucommia ulmoides, 2 parts of poria cocos, 1.5 parts of hawthorn, 3 parts of motherwort, 2 parts of uncaria, 1 part of chrysanthemum and 1 part of mulberry leaves.
5. The traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia according to any one of claims 1 to 4, which is characterized in that: the traditional Chinese medicine composition is an aqueous extract of raw material components.
6. The traditional Chinese medicine composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 5, is characterized in that: the extraction frequency of the water extract is not less than 3 times, the water extraction time is 1-3 h each time, and the water adding amount of the water extraction is 5-10 times of the total mass of the raw materials each time.
7. A traditional Chinese medicine preparation for reducing high blood pressure, high blood sugar and high blood lipid is characterized in that: the active ingredients of the traditional Chinese medicine preparation comprise the traditional Chinese medicine composition for reducing the hypertension, hyperglycemia and hyperlipidemia as claimed in any one of claims 1 to 4.
8. The traditional Chinese medicine preparation for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 7, is characterized in that: the dosage form of the traditional Chinese medicine preparation is any one dosage form in the prescription science.
9. The traditional Chinese medicine preparation for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 8, is characterized in that: the Chinese medicinal preparation is granule, tablet, pill, paste, capsule, powder, decoction, oral liquid or teabag.
10. The traditional Chinese medicine preparation for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 7, is characterized in that: the components of the traditional Chinese medicine preparation also comprise pharmaceutically acceptable auxiliary materials.
CN202011271861.5A 2020-11-13 2020-11-13 Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation Pending CN112274600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011271861.5A CN112274600A (en) 2020-11-13 2020-11-13 Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011271861.5A CN112274600A (en) 2020-11-13 2020-11-13 Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation

Publications (1)

Publication Number Publication Date
CN112274600A true CN112274600A (en) 2021-01-29

Family

ID=74397899

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011271861.5A Pending CN112274600A (en) 2020-11-13 2020-11-13 Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation

Country Status (1)

Country Link
CN (1) CN112274600A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110004018A (en) * 2019-04-26 2019-07-12 江苏伊贝实业股份有限公司 A kind of hypertension and hyperlipemia blood sugar reducing health wine
CN111494558A (en) * 2020-05-09 2020-08-07 陕西中医药大学 Strong dizzy-stopping capsule and its preparing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110004018A (en) * 2019-04-26 2019-07-12 江苏伊贝实业股份有限公司 A kind of hypertension and hyperlipemia blood sugar reducing health wine
CN111494558A (en) * 2020-05-09 2020-08-07 陕西中医药大学 Strong dizzy-stopping capsule and its preparing method

Similar Documents

Publication Publication Date Title
CN103041118B (en) Composition with effects of reducing blood sugar and reducing blood lipid
CN101612315A (en) A kind of compound Chinese medicinal preparation that is used to adjust function of human body
CN113041293A (en) Traditional Chinese medicine composition for treating atherosclerosis
CN102784366B (en) Medical composition with function of decanting and protecting liver
CN112704722A (en) Health tea for promoting digestion and regulating stomach function and preparation method thereof
CN102784248A (en) Chinese medicine composition for preventing and treating alcoholic liver injury
CN108813501A (en) With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung
CN101804110A (en) Traditional Chinese medicine preparation for purifying blood
CN104474472A (en) Broadleaf holly leaf buccal tablet capable of reducing high blood pressure, high blood lipid and high blood glucose and production method of buccal tablet
CN111249410A (en) Medicated diet beverage for protecting liver, removing toxicity, discharging fat, preventing and treating liver injury and recovering liver function
CN103202956A (en) Antihypertensive life-preserving health-care medicinal liquor
CN105687788A (en) Pharmaceutical composition capable of softening blood vessels and application thereof
CN105796753A (en) Hepatoprotection traditional Chinese medicine composition and preparation method thereof
CN112274600A (en) Traditional Chinese medicine composition for reducing high blood pressure, high blood sugar and high blood lipid and traditional Chinese medicine preparation
CN114404517A (en) Composition for gout and reducing uric acid and application and preparation method thereof
CN104587424A (en) Ginger-red date-fennel-clove bud-agilawood-containing traditional Chinese medicine composition and preparation method thereof
CN103751547A (en) Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof
CN113018398A (en) Anti-fatigue health product and preparation method thereof
CN108721557B (en) Traditional Chinese medicine composition with auxiliary protection function on gastric mucosa injury and preparation method and application thereof
KR0160402B1 (en) Composition for prevention of stress
CN116747286B (en) A Chinese medicinal composition with weight reducing effect, and its preparation method
CN114712466B (en) Medicine with weight-reducing and beautifying effects and preparation method thereof
CN102526449B (en) Drug combination for treating coronary heart diseases caused by myocardial ischemia
Postoy et al. Research about development of drugs from white willow bark and sage
CN115590936A (en) Health-care medicinal liquor and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210129